Kalaris Therapeutics, Inc. (KLRS)

4.07 -0.13 (-3.10%) USD  |  NASDAQ  |  Aug 26, 12:02
More

Kalaris Therapeutics EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for KLRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2025. Start Trial.
Date Value
August 12, 2026 --
August 11, 2026 --
July 17, 2026 --
June 15, 2026 --
May 14, 2026 --
May 13, 2026 --
May 12, 2026 --
April 16, 2026 --
March 18, 2026 --
March 17, 2026 --
March 09, 2026 --
January 09, 2026 --
January 07, 2026 --
December 23, 2025 --
December 18, 2025 --
Date Value
November 25, 2025 --
November 12, 2025 --
November 03, 2025 --
October 27, 2025 --
September 15, 2025 --
September 02, 2025 --
August 14, 2025 --
August 13, 2025 --
July 23, 2025 --
July 11, 2025 --
July 10, 2025 --
May 19, 2025 --
May 14, 2025 --
May 07, 2025 --
April 08, 2025 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade